Yu Zhang

Loop profile Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Venues

PNAS nexus

ACS pharmacology & translational science

NPJ systems biology and applications

CPT: pharmacometrics & systems pharmacology

Johns Hopkins University School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Johns Hopkins University School of Medicine Aug 17 2017

United States

PHD :: Department of Biomedical Engineering

Publications

Yu Zhang, Yuhao Qiang, He Li, Guansheng Li, Lu Lu, Ming Dao, George Em Karniadakis, Aleksander S Popel, Chen Zhao
Signaling-biophysical modeling unravels mechanistic control of red blood cell phagocytosis by macrophages in sickle cell disease. PNAS nexus 3 (2) (2024)
Yu Zhang, Yuhao Qiang, He Li, Guansheng Li, Lu Lu, Ming Dao, George Em Karniadakis, Aleksander S Popel, Chen Zhao
Signaling-biophysical modeling unravels mechanistic control of red blood cell phagocytosis by macrophages in sickle cell disease. PNAS nexus 3 (2) (2024)
Yu Zhang, Yuhao Qiang, He Li, Guansheng Li, Lu Lu, Ming Dao, George Em Karniadakis, Aleksander S Popel, Chen Zhao
Signaling-biophysical modeling unravels mechanistic control of red blood cell phagocytosis by macrophages in sickle cell disease. PNAS nexus 3 (2) (2024)
Yu Zhang, Yuhao Qiang, He Li, Guansheng Li, Lu Lu, Ming Dao, George Em Karniadakis, Aleksander S Popel, Chen Zhao
Signaling-biophysical modeling unravels mechanistic control of red blood cell phagocytosis by macrophages in sickle cell disease. PNAS nexus 3 (2) (2024)
Yu Zhang, Aleksander S Popel, Hojjat Bazzazi
Combining Multikinase Tyrosine Kinase Inhibitors Targeting the Vascular Endothelial Growth Factor and Cluster of Differentiation 47 Signaling Pathways Is Predicted to Increase the Efficacy of Antiangiogenic Combination Therapies. ACS pharmacology & translational science 6 (5) (2023)
Alberto Ippolito, Hanwen Wang, Yu Zhang, Vahideh Vakil, Hojjat Bazzazi, Aleksander S Popel
Eliciting the antitumor immune response with a conditionally activated PD-L1 targeting antibody analyzed with a quantitative systems pharmacology model. CPT: pharmacometrics & systems pharmacology (2023)
Yu Zhang, Aleksander S Popel, Hojjat Bazzazi
Combining Multikinase Tyrosine Kinase Inhibitors Targeting the Vascular Endothelial Growth Factor and Cluster of Differentiation 47 Signaling Pathways Is Predicted to Increase the Efficacy of Antiangiogenic Combination Therapies. ACS pharmacology & translational science 6 (5) (2023)
Yu Zhang, Aleksander S Popel, Hojjat Bazzazi
Combining Multikinase Tyrosine Kinase Inhibitors Targeting the Vascular Endothelial Growth Factor and Cluster of Differentiation 47 Signaling Pathways Is Predicted to Increase the Efficacy of Antiangiogenic Combination Therapies. ACS pharmacology & translational science 6 (5) (2023)
Yu Zhang, Hanwen Wang, Rebeca Hannah M Oliveira, Chen Zhao, Aleksander S Popel
Systems biology of angiogenesis signaling: Computational models and omics. WIREs mechanisms of disease 14 (4) (2021)
Yu Zhang, Christopher D Kontos, Brian H Annex, Aleksander S Popel
A systems biology model of junctional localization and downstream signaling of the Ang-Tie signaling pathway. NPJ systems biology and applications 7 (1) (2021)
Chen Zhao, Yu Zhang, Aleksander S Popel
Mechanistic Computational Models of MicroRNA-Mediated Signaling Networks in Human Diseases. International journal of molecular sciences 20 (2) (2019)
Mohammad Jafarnejad, Richard J Sové, Ludmila V Danilova, Adam C Mirando, Yu Zhang, Mark Yarchoan, Phuoc T Tran, Niranjan B Pandey, Elana J Fertig, Aleksander S Popel
Mechanistically detailed systems biology modeling of the HGF/Met pathway in hepatocellular carcinoma. NPJ systems biology and applications 5 (2019)

Yu Zhang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yu Zhang